We are pleased to announce that WuXi Biologics  has received the 2017 Asia-Pacific Best Bioprocessing Excellence Award from IMAPAC, a leading consulting firm. WuXi Biologics has been recognized for its outstanding performance for facilitating biomanufacturing excellence at enhanced speed, reduced cost and superior quality.

As an open-access biologics technology platform, WuXi Biologics opened its state-of-the-art biologics manufacturing facilities at Wuxi city in 2012, which is the first in China that met cGMP standards of the United States, the European Union, and China.

The award truly reflects all of the efforts WuXi Biologics has put forth to provide its customers with high-quality and best-in-class service to help accelerate biologics development from concept to commercialization.

Related links:

Official Press Release 

WuXi Biologics Completes Construction of Asia’s Largest Perfusion Biologics Manufacturing Facility Using Disposable Bioreactors